Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2944 (LINC02944) is a human long intergenic non-coding RNA (lincRNA): a non-protein-coding RNA gene transcribed from intergenic regions and longer than 200 nucleotides. LINC02944, like other lincRNAs, does not overlap protein-coding genes and belongs to a large and poorly-characterized class of non-coding RNA molecules. These RNAs are often tissue-specific and functionally diverse, with established roles in chromatin remodeling, gene expression regulation, and genome architecture; however, there are no published functional studies or disease associations specific to LINC02944 as of the available genomic and literature sources. It is not currently considered a therapeutic target, and no interacting drugs, known mechanisms, or biomarker applications have been described for this RNA.
None known or described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2944 (LINC02944).